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Introduction 
Patients undergoing endonasal transsphe-
noidal surgery have complex needs that re-
quire expert care and the coordination of a 
multidisciplinary team of healthcare profes-
sionals. Collaboration among health care dis-
ciplines is assumed to be an effective solu-
tion to many problems, including the quest for 
cost-effective quality care. Collaboration is a 
process of shared planning with joint respon-
sibility for outcomes. Interdisciplinary care 
also involves coordination, joint decision mak-
ing, communication, shared responsibility, 
and shared authority (Lough, Schmidt, Swain, 
Naughton, LeShan, Blackburn & Mancuso, 
1996). This article provides a literature review 
of the topic as it relates to patients undergo-
ing endonasal endoscopic pituitary surgery 
and presents an illustrative case.  
Pituitary adenomas are one of the most com-
mon intracranial neoplasm, making up about 
15% -20% of such lesions. Prolactinomas are 
the most prevalent subtypes, representing  
40% - 50% of pituitary adenomas, followed 
by non-functional adenomas accounting for 
about 30%, and other functional adenomas 
secreting growth hormone, adrenocortico-
tropic hormone, or other hormones making up 
the remainder (Kovacs & Horvath 1987; 
Kontogeorgos, 2005). 
Pituitary adenomas may be classified based 
on an anatomical approach which classifies 
pituitary tumours by size based on radiologi-
cal findings. Tumours are divided into  
microadenomas (i.e.; the greatest dimension 
is <10 mm) and macroadenomas (i.e., the 
greatest dimension is > 10 mm. An MRI scan 
is now considered the imaging modality of 
choice for the diagnosis of pituitary disorders 
because of its multiplanar capability and good 
soft tissue contrast enhancement. Sagittal 
gadolinium enhanced T1-weighted images, 
clearly displaying the anterior and posterior 
lobes and the stalk on the same plane, and 
coronal gadolinium enhanced images, dis-
playing the relation between the pituitary and 
cavernous sinuses, are optimal for identifying 
a pituitary adenoma. A 3mm thin slice typical-
ly is used to obtain optimal resolution.  
The goals of treatment of pituitary adenomas 
include relief of compression of surrounding 
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structures (e.g. optic chiasm or pituitary 
gland), normalisation of hormonal secretion 
(e.g. normalisation of hypersecretion or im-
provement in hypofunction) and improve-
ment of progressive neurological deficits. 
Interventions may include surgery, medical 
therapy, radiation therapy, or a combination 
of these modalities. The treatment of choice 
must be individualised and is dictated by the 
type of tumour, the nature of the excessive 
hormonal expression, and whether or not the 
tumour extends into the brain or other critical 
structures around the pituitary. 
The transsphenoidal microsurgical approach 
to a pituitary lesion is the most widely em-
ployed surgical approach to pituitary lesions 
and represents a major development in the 
safe surgical treatment of both hormonally 
active and non-functioning tumours. Rapid 
deterioration of vision is an immediate indica-
tion for surgery to relieve pressure produced 
by an expanding tumour mass, except in the 
case of macroprolactinomas (where inten-
sive observation with a patient on dopamin-
ergic agonists may be an acceptable alterna-
tive). Progressive deterioration of visual 
fields is often the primary neurological criteri-
on on which surgical management decisions 
are based. Conventional radiation therapy is 
an effective adjunct to the treatment of pitui-
tary tumours, and rarely used as a first-line 
therapy. The advantages of radiation therapy 
are that it is non-invasive and suitable for 
high-risk surgical patients. The clinical and 
biochemical response, however, is slow and 
may require from 2 years to 10 years for 
complete and sustained remission. In addi-
tion, radiation therapy carries a substantial 
risk of hypopituitarism (approximately 30% at 
10 years), (Sheehan, Starke, Mathieu, 
Young, Sneed, Chiang, Lee, Kano, Park & 
Niranjan, 2013). Stereotactic radiosurgery 
(SRS) may be a treatment option for patients 
with recurrent or residual adenomas.  
In acromegalic patients, impaired glucose 
tolerance, hypertension, and hyperlipidemia 
should be vigorously treated concurrently 
with definitive therapy. A multidisciplinary 
clinical approach may be required for the 
treatment of arthritis, carpal tunnel syn-
drome, obstructive sleep apnoea and prog-
Tumor Type Primary 
Therapy 
Second line 
Therapy 
Adjuvant Medical 
Therapy 
Adjuvant Radi-
ation therapy 
Additional 
therapies 
Endocrine inactive
Macroadenoma 
Surgical 
resection 
Radiation therapy Temozolamide    
for malignant recur-
rent tumors 
Fractionated 
Stereotactic 
Radiotherapy for 
invasive tumors 
Prolactinoma Dopamine 
Agonists 
(cabergoline 
or  bromo-
criptine) 
Surgical resec-
tion (refractory or 
intolerant to med-
ications) 
Temozolamide for 
atypical or malig-
nant recurrent 
tumors 
Fractionated 
Stereotactic 
Radiotherapy for 
invasive tumors 
Growth Hormone
(acromegaly) 
Surgical 
resection 
Somatostatin 
analogues 
(octreotide or 
pasireotide) 
Dopamine agonists 
or growth hormone 
antagonists 
(pegvisomant) 
Fractionated 
Stereotactic 
Radiotherapy for 
invasive tumors 
Adrenocorticotropic 
Hormone (ACTH)
(Cushing disease) 
Surgical 
resection 
Steroidogenesis 
inhibitors, 
(mitotane, 
metyrapone, 
ketoconazole, 
aminoglute-
thimide) 
mifepristone Fractionated 
Stereotactic 
Radiotherapy for 
invasive tumors 
Hypophysecto-
my or  bilateral 
adrenalectomy 
Thyroid–stimulating 
hormone (TSH)
(rare) 
Surgical 
resection 
Thyroid hormome 
inhibitors 
Somatosatin    
Analogues 
Fractionated 
Stereotactic 
Radiotherapy for 
invasive tumors 
Gonadotroph   
secreting
Ovarian   
Hypersecretion 
syndrome
(rare) 
Surgical 
resection 
Radiation therapy none Fractionated 
Stereotactic 
Radiotherapy for 
invasive tumors 
Pituitary
Carcinomas 
Surgical 
resection 
Radiation and  
Chemotherapy 
Somatostatin ana-
logues for GH and 
ACTH producing 
carcinomas 
Dopamine ago-
nists for PRL 
producing carci-
nomas 
Table 1 (Above): Pituitary Tumour Subtypes and Treatment Option Overview. 
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nathism. Mortality is related primarily to cardi-
ovascular and respiratory diseases. 
Given the insidious and often non-specific 
symptoms with pituitary adenomas, there is a 
significant delay between symptom onset and 
definitive therapy.  In some instances, the 
early clinical manifestations may even lead to 
erroneous diagnoses for patients with non-
functional pituitary adenomas. In some cas-
es, patients are only diagnosed once the tu-
mour has enlarged to the point of causing 
pituitary dysfunction and/or altered visual 
fields and decreased visual acuity (Ebersold, 
Quast, Laws, Scheithauer & Randall, 1986; 
Berkmann, Schlaffer, Nimsky, Fahlbusch & 
Buchfelder, 2014). Making an appropriate 
diagnosis in a timely fashion and directing the 
patient towards an experienced team special-
ised in pituitary pathologies is essential for 
the patient’s well-being.  The multidisciplinary 
concept is important in the pre-operative, op-
erative, in-patient and long-term follow-up 
care of patients with a pituitary lesions and 
offers the best chances of favourable out-
come.  We review the key elements that as-
sure the success of a multidisciplinary team 
and present how this approach has been im-
plemented in a centre dedicated to the man-
agement of pituitary lesions for optimal out-
comes (McLaughlin, Laws, Oyesiku, Katznel-
son & Kelly, 2012). 
Teamwork for Better Patient Outcome 
In our current medical system, which encour-
ages specialisation in specific fields of inter-
est such as skull base endoscopic surgery, it 
is realistically impossible for one single physi-
cian to provide holistic care. The complex 
needs of patients, families, communities and 
populations are not usually amenable to the 
actions of single care providers in isolation 
from colleagues of other disciplines. Team-
work is recommended in order to pool skills, 
experience and knowledge to ultimately yield 
the best overall outcome for patients (Fagin 
1992). In multidisciplinary teams, members 
coordinate their efforts to fulfil goals set forth 
by the team (Hamric, Hanson, Tracy & 
O’Grady, 2013). This type of teamwork as-
sures greater flexibility and interchangeability 
between members. Multidisciplinary also 
serves to achieve greater resource efficiency 
by reducing duplication in a patient’s care, by 
sealing potential gaps in care management 
and by decreasing the risk of errors with the 
use of protocols accepted by members of the 
team.   
Implementation of a Multidisciplinary   
Approach  
Multiple groups around the world have con-
centrated their efforts on the care of patients 
with pituitary pathologies. We present an 
overview of how members of a multidiscipli-
nary team specifically designed for pituitary 
pathologies interact at various aspects of the 
patient’s overall care (Figure 1). 
Pre-Operative Care 
The primary care physician is a central player 
in the pre-operative care of most patients. 
Primary care physicians coordinate the initial 
investigation, including endocrine work-up, 
ophthalmological assessment, neurological 
evaluation and radiological investigation. 
Referring physicians, including primary care 
physicians, endocrinologist, neuro-
ophthalmologist, and neurosurgeons, should 
seek to refer their patients to a team special-
ised in pituitary lesions, capable of tailoring 
the surgical procedure and adjuvant therapy 
to each patient’s specific situation. 
The initial conversation with the team’s nurse 
practitioner provides an opportunity for the 
patient to voice questions and concerns to 
which the practitioner can address. The nurse 
practitioner explains the consultation process 
to the patient and ensures that pertinent data 
such as pituitary hormonal blood evaluations, 
neuro-imaging and visual fields if indicated 
are available at the time of consultation.   
Figure 1 (Above): Diagram demonstrating the patient-
centric model of the multidisciplinary approach to the 
pituitary patient.  
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During this initial consultation, a detailed clin-
ical history and physical examination are per-
formed.  Images and hormonal test results 
are reviewed with the patient and their family, 
and the likely diagnosis is presented. In 
many instances, the diagnosis is clear-cut. 
However, in certain cases, the diagnosis may 
be uncertain due to ambiguous imaging or 
inconclusive hormonal test results. Thus, 
some patients may require additional evalua-
tion before a recommendation regarding the 
optimal treatment can be made. Once this 
key data is available, definitive treatment op-
tions are discussed in detail including indica-
tions and alternatives to endonasal surgery, 
medical treatment options and the possible 
need for radiosurgery or radiotherapy. The 
need for hormonal replacement therapy is 
also discussed. Providing this data helps the 
patient process the information and under-
stand the following steps. For those who ulti-
mately require surgery, meeting the surgical 
team pre-operatively allows patients to direct 
specific questions to each team member. 
Once the surgical team has discussed the 
treatment management options, the nurse 
practitioner can go over key questions re-
garding the post-operative period from the 
patient’s stay in recovery room to the first 
weeks after surgery to give the patient appro-
priate expectations. They will also help coor-
dinate the pre-operative medical evaluation, 
including cardiac or pulmonary clearance if 
required as well as consultations with other 
medical specialists and complementary im-
aging.  
In the 48 hours preceding surgery, the pre-
operative work-up should be verified by the 
entire team and the patient is contacted if 
any further verification is required. As the 
patients are usually not admitted to the hos-
pital the night before surgery, communication 
with the nurses in the pre-operative unit is 
essential to verify that the chart is complete 
and that all inquiries have been addressed. 
This is essential to prevent any delays on the 
morning of surgery. 
In research institutions, contributing the 
tumour specimen to a tissue and/or blood 
bank should be offered on a voluntary basis 
to each patient prior to surgery. This is intro-
duced by the surgical team and the consent 
may be obtained either by the research 
nurse, the investigator or the nurse practition-
er. 
Intra-Operative Care 
Peri-operatively, the anaesthetist is an inte-
gral member of the care team. For some pitu-
itary tumour patients, such as those with ac-
romegaly or Cushing’s disease, securing the 
airway may be a challenge and may require 
special intubation techniques. The pre-
operative discussion with anaesthetist should 
include specific concerns, including blood 
pressure management and intra-operative 
medications. In particular, the necessity or 
contraindication for peri-operative steroids 
should be discussed. The operation is per-
formed by a dedicated team, combining skull 
base neurosurgeons and head and neck sur-
geons, both versatile in endonasal approach-
es. Combining expertise on a regular basis 
optimises the surgical team’s success in 
comparison with casual interaction.  Intra-
operative pathological assessment often con-
firms the presumed pre-operative diagnosis. 
Detailed analysis of the histological charac-
teristics and molecular signature are im-
portant for the adjuvant treatments recom-
mended after surgery. 
Post-Operative Care 
Following the endonasal transsphenoidal 
resection of pituitary tumour, close observa-
tion and monitoring in a skilled nursing unit is 
required for the initial 24 hours.  Intensive 
care units are reserved for the unstable or 
high acuity patient (e.g. requiring vasopres-
sor or insulin drips). The surgical team must 
inform the intensivist  about the patient’s clin-
ical history, pre-operative neurological status, 
hormone deficiencies, intervention per-
formed, occurrence of any intra-operative 
complication and total blood loss.  In cases of 
pre-operative hypopituitarism, functional pitu-
itary tumours or surgical procedures that 
might have altered the pituitary gland or pitui-
tary stalk, an endocrinologist should manage 
the patient’s hormone balance.   
Standing orders and critical pathways are 
vital tools for nurses in anticipating complica-
tions and therefore improving patient out-
comes.  Serial neurological examinations and 
prompt reporting of any changes are critical 
in identifying neurological complications. 
Once identified, the treating physician must 
be advised. Complications such as diabetes 
insipidus and cerebrospinal rhinorrhoea (CSF 
leak) associated with endonasal surgery may 
result in prolonged hospitalisation and wors-
ened functional outcome (Eisenberg & Red-
ick, 1998). A dedicated, multidisciplinary clini-
cal practice with large annual volume of 
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transsphenoidal surgery is important for safe, 
successful outcomes in patients with pituitary 
tumours (Shahlaie, McLaughlin, Kassam & 
Kelly, 2010). In conjunction with the surgical 
team, the hospital case manager initiates dis-
charge planning as soon as the patient ar-
rives to the ward, allowing for a thorough re-
view of the patient’s condition facilitating the 
discharge home or to other facilities when 
necessary. 
The Patient’s Support System 
The patient’s family is an important element in 
the pre-operative care period.  Most patients 
have a family member that stays at bedside 
throughout their hospitalisation. It is crucial 
that they understand what is to be expected in 
the post-operative period. They should be 
informed on signs and symptoms to observe. 
The family members also play a key role in 
the patient’s rehabilitation as they can stimu-
late progressive oral intake and mobilisation, 
when indicated. Early ambulation prevents 
the complications seen with immobility, such 
as atelectasis, pneumonia, deep vein throm-
bosis and pulmonary embolus (Prather, For-
syth, Russell & Wagner, 2003). Hence, family 
cooperation should be recognised and en-
couraged. 
Discharge from the hospital is organised 
when the entire team believes the patient is 
stable.  For typical patients undergoing endo-
scopic endonasal resection of a pituitary ade-
noma or Rathke’s Cleft Cyst, this occurs on 
the second post-operative day. For patients 
with more complex operations, such as ex-
tended skull base approaches for cranio-
pharyngiomas, chordomas or meningiomas, 
length of stay can range from three to seven 
days. The patient’s family or immediate care-
giver should always be involved in this pro-
cess since they will be looking after the pa-
tient at home. Post-operative instructions spe-
cific to endonasal surgery are given to the 
patient prior to discharge and include recom-
mendations for activities of daily living, medi-
cations to take and/or avoid, allowed physical 
activity, and appointments after hospital dis-
charge. These discharge instructions also 
mention signs and symptoms that would be 
more worrisome and that should trigger a call 
to the treating team. The patients are also told 
that if they have permanent pituitary insuffi-
ciency (hypopitutiarism) and require long term 
steroids (prednisone or hydrocortisone) and/
or DDAVP, they should carry a medic alert 
card in their wallet and wear a medic alert 
bracelet. This will alert medical personnel to 
the need for additional hormone administra-
tion in an emergency situation. A serum sodi-
um level is evaluated on the 4th or 5th day 
after surgery. Delayed hyponatraemia, at-
tributed to the syndrome of inappropriate se-
cretion of antidiuretic hormone (SIADH), typi-
cally occurs in a delayed fashion following 
transsphenoidal resection of pituitary lesions. 
In a series of 99 consecutive patients who 
underwent transsphenoidal surgery for pitui-
tary adenomas, nine patients developed de-
layed hyponatraemia, seven of whom were 
symptomatic. Of these seven patients, four 
had been discharged from the hospital and 
required readmission on postoperative Day 7 
to 9. In the nine patients who developed hy-
ponatraemia, on the average sodium levels 
began to fall on Day 4 and reached a nadir on 
Day 7 (Kelly, Laws & Fossett, 1995). Educa-
tion at discharge about common symptoms of 
SIADH, such as nausea, confusion, fluid re-
tention, and lethargy, is important for early 
recognition and prompt treatment.  When left 
untreated, severe delayed hyponatraemia can 
result in coma or death. 
Post-Operative and Long-term Follow-Up 
Care 
Patients are typically seen by the surgical 
team 7-10 days after the surgery. After endo-
nasal endoscopic surgery, the head and neck 
surgeon will perform outpatient sinonasal en-
doscopy and debridement at least 2-3 times 
over multiple months. The definitive pathology 
results are discussed with the patient usually 
at the first postoperative visit in the clinic. The 
possible needs for adjuvant treatments such 
as medical therapies for patients with acro-
megaly or radiosurgery for residual invasive 
adenomas are also discussed with the pa-
tient. In many patients, these decisions may 
need to be delayed for several months or 
years with frequent hormonal evaluation and 
pituitary imaging. The nurse practitioner is key 
in coordinating post-operative care and possi-
ble adjuvant therapy by the endocrinologist, 
medical oncologist and radiation oncologist. 
It is important that the treatment plan be com-
municated to the patient’s primary physician 
to keep all caregivers informed. Patients 
should be referred back to their endocrinolo-
gist four to six weeks after surgery to assess 
the status of their pituitary function and deter-
mine if any hormonal replacement is needed 
or should be adjusted. Patients with macroad-
enomas undergo a follow-up pituitary MRI at 
three months after surgery. Patients with 
functional adenomas obtain an initial post-
operative baseline MRI, but are subsequently 
monitored biochemically, based on their en-
docrinopathy.  Patients with non-functional 
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inactive pituitary adenomas are followed with 
serial imaging, with progressively longer inter-
vals between exams, with stable disease. 
Faithful adherence to a schedule of follow-up 
pituitary imaging allows for early detection of 
tumour recurrence and timely treatment, in-
cluding either repeat surgery with or without 
radiation therapy and chemotherapy. Nurses 
who care for patients during the follow-up 
phase of pituitary management face the spe-
cial challenge of ensuring that these individu-
als, who may no longer be symptomatic, re-
turn for evaluation at regular intervals. The 
nurse practitioner must emphasise the im-
portance of maintaining follow-up appoint-
ments with all team members namely the en-
docrinologist, neuro-ophtalmologist, surgical 
team, radio-oncologist and medical oncolo-
gist.   
Educational Opportunities 
Education opportunities focusing on the care 
of patients with pituitary lesions is an ongoing 
experience. Ongoing lectures and review of 
journal articles continue to help nurses devel-
op their knowledge and improve practice.  A 
Neuroscience Nursing Symposium has been 
developed in our Center to keep nurses up-
dated on state of the art treatments for pitui-
tary pathologies and on future trends. Strate-
gies that may further improve patient out-
comes include establishing guidelines for pi-
tuitary tumour centres of excellence and more 
focused residency and fellowship training in 
endonasal endoscopic transsphenoidal sur-
gery.  
The impact of the internet on patient educa-
tion and support is very vital. We correspond 
regularly with patients who research online for 
information and guidance. These patients are 
referred to online forums and patient associa-
tions that offer the possibility to discuss with 
other patients with similar pathologies.  We 
offer a community outreach program where 
different specialties collaborate to educate the 
general population regarding pituitary tu-
mours.  Our Center offers a patient focused 
pituitary symposium including neurosurgeons, 
head and neck surgeons, endocrinologist, 
radiation oncologist, patient advocates, nurse 
practitioners and research nurses. As patients 
become increasingly involved in researching 
diagnoses and medical treatment options 
online, we must be able to provide the most 
up-to-date and comprehensive information via 
the internet. Our practice website is updated 
regularly to have the current information and 
publications for patient’s references. 
Case Study 
A 40 year old man presented with a 7 year 
history of fatigue and low energy with a 20 
year history of low testosterone treated with 
testosterone supplements. For over a year, 
the patient has noticed decreased libido, anxi-
ety as well as worsening vision, predominant-
ly in the right eye. His pre-operative total tes-
tosterone was 180 ng/dl (normal >250 ng/dl) 
with LH at 2.2m/iu/ml (low normal); prolactin 
was mildly elevated at 29.7ng/ml; IGF-1 was 
230 ng/ml (age appropriate normal); thyroxin 
was 6.0 ng/ml and TSH was 1.5ng/ml (both 
normal); ACTH was 25 pg/ml and cortisol was 
12 ug/dl (both normal). A radiographic image 
of the brain and pituitary demonstrated large 
pituitary macroadenoma with degenerative 
changes and subacute haemorrhage and se-
vere chiasmal compression (figure 2).  
On neurological examination visual acuity 
was diminished on the right (20/50) and nor-
mal on the left (20/20). There was mild bitem-
poral hemianopsia on confrontational exami-
nation, worse in the right eye. He was other-
wise neurologically intact. He underwent en-
donasal endoscopic removal of an endocrine 
inactive macroadenoma and sellar reinforce-
ment with an abdominal fat graft. The post-
operative MRI showed gross total resection of 
the pituitary adenoma. His immediate post-
operative prolactin level was 19.9ng/ml; corti-
sol 5.6ng/ml. His visual fields deficits resolved 
and visual acuity improved to 20/25 OD and 
20/20 OS. Pathological evaluation confirmed 
pituitary adenoma, ACTH staining; no fea-
tures of atypia or malignancy and Ki-67 is 
Figure 2 (Above): Pre-operative (A&B) and post-
operative (C&D) MRI images of the case study patient. 
Note the large macroadenoma with evidence of hemor-
rhage (arrow) and gross-total resection of this tumor. 
Note the normal, decompressed and preserved pituitary 
gland now visible in the post-operative images 
(arrowheads). 
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<1% (pathological grading marker for neuro-
endocrine tumours). The patient was able to 
be discharged on the second post-operative 
day without complications. We saw him on 
follow-up 4 months after surgery and he has 
had an improvement in his vision. His visual 
acuity revealed 20/25 OD and 20/20 OS. His 
pituitary hormonal function was normal. It 
was recommended that he have a repeat 
hormonal function test within 2 months and 
follow-up visit with his endocrinologist. He 
was to have a follow-up appointment  and 
repeat MRI in one year.  
This case illustrates the importance of a mul-
tidisciplinary approach with members experi-
enced in pituitary pathologies. The patient 
was seen by a medical physician, then re-
ferred to an endocrinologist, an ophthalmolo-
gist and neurosurgeon. The unfortunate situ-
ation in this case is that the diagnosis of pitui-
tary tumour could have been investigated 
early on if an early MRI was performed. The 
patient had a pituitary apoplectic event due to 
the enlarged tumour.  
Conclusion 
Multidisciplinary team work is essential to 
optimally manage patients with pituitary ade-
nomas and related lesions, resulting in im-
proved quality of care and patient outcomes. 
As illustrated, throughout the process of pre-
operative, peri-operative and post-operative 
care, numerous specialists and team mem-
bers must be carefully integrated in this pro-
cess. At pituitary centres of excellence, prac-
titioners should demonstrate that endonasal 
surgery patients can be cared for safely, ef-
fectively and efficiently through multidiscipli-
nary treatment paradigm. In order to adminis-
ter excellence in nursing care, key contribu-
tion of the neuroscience nurses include main-
taining a holistic view of the patient, maintain-
ing the patient and family central to care and 
decision making, advocating for the patient 
and family interests, and educating the pa-
tient and family. The foundation for imple-
mentation of these and other aspects of care 
is critical thinking and highly developed clini-
cal reasoning skills. These skills are neces-
sary for both independent decisions by the 
nurse practitioner and participation in multi-
disciplinary settings. 
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